openPR Logo
Press release

Better Heart Health: Better Life Quality

04-27-2017 05:06 PM CET | Health & Medicine

Press release from: Allied Academies

Heart disease remains the leading cause of death all over the world. Cardiomyopathy, enlarged heart, heart attack, heart valve disease, congenital heart disease, heart muscle disease, pericarditis, Marfan syndrome, Coronary heart disease, Arrhythmias (heart rhythm problems ), and heart defects are the various types of “heart diseases” affecting the heart and blood vessels. The total number of cardiovascular deaths had increased globally to 17.5 million in 2005 from 14.4 million in 1990. Of these, a majority were attributed to coronary heart disease and stroke. According to the American Heart Association, Coronary heart disease is the leading killer of men and women. In addition to lifestyle behaviours, which are the biggest cause of death and disability, medical conditions like high blood pressure, high cholesterol and diabetes also play a major role in cardiovascular health.
Experts around the globe therefore highlight the importance of addressing both lifestyle choices and existing cardiovascular risk factors to combat heart disease. Major on going researches focus on addressing these issues for preventing and curing heart diseases, in order to reduce death rates caused by them.
We are bringing forth the Heart Diseases 2017 conference during September 18-19, 2017 at Toronto, Canada, where scientists, doctors, researchers, academicians, from around the world are coming together to address the issues and advancements in their respective ongoing research on various heart diseases. We will be organizing plenary sessions, talks, Young Research Forum (students), poster presentation, video presentation and workshops in this conference. This is going to be a major platform for students where they will get an opportunity to meet the leaders around the world which helps them doing some ground breaking research in the future.
We welcome you to this conference to join us as speaker, delegate, media partners or exhibitors.
If you are interested, kindly go through the link http://heartdiseases.alliedacademies.com/ for further information.
Phone:+1800-858-2189/+44800-086-8979
Email:heartdiseases@alliedconferences.org

The Allied Academies' family of journals have been performing very well in Business and Management and are a perfect fit for our readers. We provide our authors and readers a platform that serves them well and helps them share their work with the global community. We are expanding the focus of Allied Academies beyond Business and Management Journals to incorporate scientific areas as well.
Our primary focus is to support original research work, share and exchange the ideas of authors from various institutions with the world. Our journals act as successful outlets for numerous scholars including teaching professors and researchers.

Allied Academies
85 Great Portland St
Marylebone
London W1W 7LT, UK
Phone: +1 800-858-2189
+44 800-086-8979
Email: heartdiseases@alliedconferences.org

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Better Heart Health: Better Life Quality here

News-ID: 517572 • Views:

More Releases from Allied Academies

Are you passionate about nanoscience and its impact on healthcare? Then mark your calendars for the Nanoscience Conference 2023
Are you passionate about nanoscience and its impact on healthcare? Then mark you …
Nanoscience 2023 UPDATE!! Meet you all in Madrid, Spain on December 07-09, 2023. We ecstatically welcome you all to the "27th International Conference on Advanced Nanoscience and Nanotechnology". This conference is meticulously scheduled during December 07-09, 2023 in Madrid, Spain. For more details, please visit: https://nanoscience.alliedacademies.com With an exciting theme, "Investigate the future prospects in Nanoscience and Nanotechnology", this year we can provide you with a world-class scientific program spanning all areas of
Stress Management 2023
Globally, the COVID-19 pandemic affected not only the financial status but also the mental health of the individuals drastically which increased the stress management market to USD 18,700.9 million and expected to increase at a CAGR of 3.8% during the forecast period. Globally, 10% of the children encounter any least one of the mental disorders. The preliminary treatment could be discussing the issue with the cherished circle, whereas professional
Current trends in Rheumatology, Orthopedics, and Arthroplasty
Current trends in Rheumatology, Orthopedics, and Arthroplasty
2nd International Conference on Rheumatology, Orthopedics and Arthroplasty December 05-06, 2022 | Dubai, UAE Theme: Current Trends in Rheumatology, Orthopedics and Arthroplasty Rheumatology 2022 will provide an international platform for all Speakers, Delegates, Surgeons, Research Scholars, Orthopedic Physicians, Orthopedic Surgeons, Rheumatologists, Orthopedic and Rheumatology Research Fellows, Orthopedic and Rheumatology Faculty, Directors and Chair Persons, Health Care Professionals, Orthopedic and Rheumatology Medical Students, Orthopedics Medical Colleges, Universities, Orthopedics Devices Designers etc. Audience Profile: ·
4th International Conference on Materials Science and Materials Chemistry
The 4th International conference on Materials Science and Materials Chemistry is an international Scientific gathering which provides a common place for all the stakeholders of materials research and industry as like scientists, researchers, industrialists, entrepreneurs, start-ups, young research fellows, academic institutions, laboratories and many others to share and discuss the current trends in Materials Research. Come and explore the trends in materials research! To register: https://materialschemistry.alliedacademies.com/registration For brochure: https://materialschemistry.alliedacademies.com/brochure-download To submit your abstract:

All 4 Releases


More Releases for Heart

Heart disease and Heart Attacks - Kaffailham.gr
Καρδιολόγος Αθηνα - https://kaffailham.gr When people talk about heart disease or heart attacks. The arteries that they are talking about are the arteries that actually provide blood to the heart. Remember the heart itself is a muscle. It itself needs oxygen. So you have these arteries right over here, the red tubes. Those are arteries. and then the blue ones are veins. They're taking the de-oxygenated blood away from the tissue
Artificial Heart Implant Market May See a Big Move | Major Giants Jarvik Heart, …
The Latest survey report on Artificial Heart Implant Market sheds lights on changing dynamics of each of the subsegments of Industry. As the shift to value continues, Artificial Heart Implant organizations have the dual challenge of increasing interoperability to improve clinical performance and the patient experience. Some of the companies listed in the study from complete survey list are Medtronic, Boston Scientific, Abbott, Terumo, B.Braun, SynCardia, BiVACOR, CARMAT, ReinHeart TAH
Heart Pump Device Market - Potential Innovations 2025 | Terumo, Jarvik Heart
Heart Pump Device Market: Snapshot Heart pump devices are essentially mechanical pumps playing the role of ventricular assist devices. These are surgically implanted and are used for temporarily supporting the functions of heart in people with weak heart or irregular blood flow. These devices are notably used as a bridge to cardiac transplantation for patients suffering with end stage heart failure. They can also be used in patients during and after
Congestive Heart Failure (Heart Failure)-Pipeline Review, H2 2017
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Congestive Heart Failure (Heart Failure)-Pipeline Review, H2 2017, provides an overview of the Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline landscape. Heart failure is also known as congestive heart failure (CHF). CHF is a condition in which the heart is no longer able to pump out enough oxygen-rich blood. Symptoms include cough, fatigue, weakness, faintness, loss of appetite, swollen (enlarged) liver
Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017, provides an overview of the Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline landscape. Heart failure is also known as congestive heart failure (CHF).
Congestive Heart Failure (Heart Failure) Market Research Report
Latest industry research report on: Congestive Heart Failure (Heart Failure) Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts GlobalData's clinical trial report, Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H1, 2017" provides an overview of Congestive Heart Failure (Heart Failure) clinical trials scenario. This report provides top line data relating to the clinical trials on Congestive Heart Failure (Heart Failure). Report includes an